Literature DB >> 3323775

Dextropropoxyphene overdose. Epidemiology, clinical presentation and management.

A A Lawson1, D B Northridge.   

Abstract

This paper comprehensively reviews the worldwide situation regarding acute overdosage of dextropropoxyphene (propoxyphene). The changing epidemiology of this type of poisoning over the last 20 years is described with discussion of concurrent trends and, in particular, the effects of different preventive measures adopted in various countries. The clinical pharmacology of dextropropoxyphene relevant to the clinical toxic effects resulting from acute overdosage is described, and the management is detailed. In particular, the importance of early diagnosis and treatment is stressed in view of the potentially lethal complications that may suddenly occur with this poisoning. Recommendations for the correct use of the specific narcotic antagonist, naloxone, are made, together with other intensive supportive measures. As dextropropoxyphene is frequently taken together with other toxic agents, the concomitant effects of alcohol and sedative drugs are described and the treatment of paracetamol (acetaminophen) in combination with dextropropoxyphene is emphasised. The most effective preventive measures for the future are suggested, but caution is advised regarding the prescription for 'at risk' patients of alternative analgesics, which may be no safer in overdosage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323775     DOI: 10.1007/BF03259877

Source DB:  PubMed          Journal:  Med Toxicol Adverse Drug Exp        ISSN: 0113-5244


  86 in total

1.  [Fatal poisoning with dextropropoxyphene].

Authors:  H Christensen
Journal:  Ugeskr Laeger       Date:  1975-10-27

2.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

3.  Analgesia, plasma levels, and dosage of propoxyphene.

Authors:  S O Waife; C M Gruber; B E Rodda; J F Nash
Journal:  Int J Clin Pharmacol Biopharm       Date:  1976-04

4.  Propoxyphene and norpropoxyphene concentrations in blood and tissues in cases of fatal overdose.

Authors:  A J McBay
Journal:  Clin Chem       Date:  1976-08       Impact factor: 8.327

5.  1985 Annual Report of the American Association of Poison Control Centers National Data Collection System.

Authors:  T L Litovitz; S A Normann; J C Veltri
Journal:  Am J Emerg Med       Date:  1986-09       Impact factor: 2.469

6.  Deaths involving propoxyphene. A study of 41 cases over a two-year period.

Authors:  W Q Sturner; J C Garriott
Journal:  JAMA       Date:  1973-03-05       Impact factor: 56.272

7.  Treatment of dextropropoxyphene poisoning.

Authors:  V Hunt
Journal:  Br Med J       Date:  1973-03-03

8.  Dangers of dextropropoxyphene.

Authors: 
Journal:  Br Med J       Date:  1977-03-12

9.  The role of naloxone infusions in the treatment of overdoses of long half-life narcotic agonists: application to nor-methadone.

Authors:  G K Gourlay; K Coulthard
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

10.  Self-poisoning with dextropropoxyphene and dextropropoxyphene compounds: the USA experience.

Authors:  B S Finkle
Journal:  Hum Toxicol       Date:  1984-08
View more
  2 in total

1.  Pharmacokinetics of dextropropoxyphene and nordextropropoxyphene in young and elderly volunteers after single and multiple dextropropoxyphene dosage.

Authors:  R J Flanagan; A Johnston; A S White; P Crome
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

2.  A multicentre study of coproxamol poisoning suicides based on coroners' records in England.

Authors:  K Hawton; S Simkin; D Gunnell; L Sutton; O Bennewith; P Turnbull; N Kapur
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.